Cancer risk with JAK inhibitors versus TNF inhibitors

被引：0
|
作者：
Thorley, Jennifer
机构：
来源：
LANCET RHEUMATOLOGY | 2023年 / 5卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：e252 / e252
页数：1
相关论文
共 50 条
  • [41] JAK inhibitors: risk of major adverse cardiovascular events
    Reactions Weekly, 2025, 2052 (1) : 8 - 8
  • [42] JAK inhibitors increase risk of respiratory tract infections
    Reactions Weekly, 2020, 1806 (1) : 13 - 13
  • [43] JAK inhibitors and the risk of infection: a meta-analysis
    Ran, Hao-Long
    Liu, Huan
    Xu, Wen-Ting
    Zhang, Jin-Rui
    Chen, Wei
    Dong, Han-Yue
    Li, Hongmin
    Tan, Cheng
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2025, 317 (01)
  • [44] JAK inhibitors and risk of B-cell lymphomas
    Rumi, Elisa
    Zibellini, Silvia
    BLOOD, 2019, 133 (21) : 2251 - 2253
  • [45] Biologics Versus JAK Inhibitors. Part II: Risk of Infections. A Narrative Review
    Mansilla-Polo, Miguel
    Morgado-Carrasco, Daniel
    DERMATOLOGY AND THERAPY, 2024, 14 (08) : 1983 - 2038
  • [46] The use of JAK inhibitors for low-risk myelofibrosis
    Alimam, Samah
    McLornan, Donal
    Harrison, Claire
    EXPERT REVIEW OF HEMATOLOGY, 2015, 8 (05) : 551 - 553
  • [47] The cardiovascular risk of JAK inhibitors in treating rheumatic diseases
    Kwan, Alexander
    Ingrid, Elvina
    Jiang, Matthew
    Lim, Keith K. T.
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (08)
  • [48] TNF inhibitors increase malignant melanoma risk
    Reactions Weekly, 2013, 1449 (1) : 3 - 3
  • [49] TREATMENT PERSISTENCE OF SUBCUTANEOUS TNF-ALPHA INHIBITORS AND JAK INHIBITORS AMONG AUSTRALIAN PATIENTS WITH RHEUMATOID ARTHRITIS
    Puig, Andrea
    Chien, Tirian
    O'Sullivan, Catherine
    INTERNAL MEDICINE JOURNAL, 2020, 50 : 24 - 24
  • [50] TNF inhibitors and cardiovascular risk: Friend or foe?
    Gelfand, Joel M.
    Garshick, Michael
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024, 38 (06) : 995 - 996
12345